Advances in Cardiovascular Toxicity Associated with Targeted Therapy for Breast Cancer
Breast cancer is one of the most common malignant tumors in women. Because of the abundance of diagnosis and treatment methods and the wide application of targeted therapy drugs in recent years, the survival time of breast cancer patients is longer than before and the mortality rate shows a downward...
Main Authors: | WANG Yan, MENG Wenjing, TONG Zhongsheng |
---|---|
Format: | Article |
Language: | zho |
Published: |
Magazine House of Cancer Research on Prevention and Treatment
2021-05-01
|
Series: | Zhongliu Fangzhi Yanjiu |
Subjects: | |
Online Access: | http://html.rhhz.net/ZLFZYJ/html/8578.2021.20.1232.htm |
Similar Items
-
Cardiovascular Toxicity and Management of Targeted Cancer Therapy: An Overview for Generalists
by: Bossaer, John B., et al.
Published: (2016) -
Onco-Cardiology: A Specialty that Goes Beyond Managing Cardiovascular Toxicity
by: Elie Mouhayar
Published: (2018-11-01) -
Editorial: Cardiovascular toxicities of breast cancer treatment: emerging issues in cardio-oncology
by: Sharad eGoyal, et al.
Published: (2015-03-01) -
Current advances in biomarkers for targeted therapy in triple-negative breast cancer
by: Fleisher B, et al.
Published: (2016-10-01) -
Zebrafish Models of Cancer Therapy-Induced Cardiovascular Toxicity
by: Sarah Lane, et al.
Published: (2021-01-01)